Indeed, as seen previously, simultaneous administration of the selective SERT inhibitor sertraline and the selective DAT inhibitor vanoxerine resulted in a weak, albeit significant, reversal of Parkinsonism. The gene discussed is SLC6A3; the disease is Parkinson disease.